Symposia: Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, clinical trials, adult, Translational Research, epidemiology, Clinical Research, Combination therapy, Diseases, patient-reported outcomes, Therapies, survivorship, Study Population, Human, Transplantation, Vaccines
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, clinical trials, adult, Translational Research, epidemiology, Clinical Research, Combination therapy, Diseases, patient-reported outcomes, Therapies, survivorship, Study Population, Human, Transplantation, Vaccines
Saturday, December 10, 2022: 4:00 PM-5:30 PM
353-355
(Ernest N. Morial Convention Center)
Moderators:
Richard J. Lin, MD, Memorial Sloan Kettering Cancer Center
and
Gregory M Guilcher, MD, BSc, FRCPC, Section of Pediatric Hematology, Oncology and BMT, University of Calgary, Alberta Children’s Hospital
Disclosures:
Lin: Kite, A Gilead Company: Consultancy; Magenta Therapeutics: Consultancy. Guilcher: Bluebirdbio: Other: PI of Project Sickle Cure, a Sickle Cell Transplant Advocacy and Research Alliance study partially funded by bluebirdbio, Research Funding; Bristol Myers Squibb: Other: I serve on a steering committee for a clinical trial for which BMS provides funding., Research Funding.
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH